Stephanie Seremetis

Title: The Innovative Contributions of Stephanie Seremetis

Introduction

Stephanie Seremetis is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the area of human B lymphocyte transformation. Her work has implications for the production of human monoclonal antibodies, which are crucial for various medical applications.

Latest Patents

Stephanie holds a patent titled "Method for transforming human B lymphocytes." This patent discloses a method for transforming human B-cells by infecting them with Epstein-Barr virus, followed by the transformation of the infected cells with an activated human ras gene. The transformed cells are useful for producing human monoclonal antibodies, either without further manipulation or after fusion with antibody-secreting cells. She has 1 patent to her name.

Career Highlights

Stephanie is affiliated with New York University, where she conducts her research and contributes to advancements in biotechnology. Her work is recognized for its potential to enhance the production of therapeutic antibodies, which are vital in treating various diseases.

Collaborations

One of her notable collaborators is Riccardo Dalla-Favera, a respected figure in the field of cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.

Conclusion

Stephanie Seremetis is a trailblazer in the field of biotechnology, with her innovative methods for transforming human B lymphocytes paving the way for advancements in monoclonal antibody production. Her contributions continue to impact the medical field positively.